BUSINESS● LOW3h ago · Sep 4, 2026, 4:14 PM
MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?
Yahoo Finance · global
The approval of MIMRYLO resulted in $275 million in payments for Protagonist (PTGX), prompting a discussion about the effectiveness of royalties as a commercial model. This highlights a significant financial and strategic development in the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS14m agoCatalyst watch: Apple's high-stakes iPhone event, Oracle, CPI, and the NFL returnsSeeking Alpha TechBUSINESS47m agoWomen accounted for almost all of job gains in August. Here's whyCNBCBUSINESS49m agoBauxite transformation: how Guinea wants to impose its refineriesJeune AfriqueBUSINESS51m agoFat cattle lose momentum in Cañuelas, but cows find support in exportsClarín